Guanghai Dai

5PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 25, 2026
Fluorescent Multiplex Immunohistochemistry (mIHC) Analyses of Local Advanced Gastric Cancer Patients After Neoadjuvant Chemotherapy Revealed the Status of Tumor-Infiltrating Immune Cells and Predicted the Clinical Outcome.

|Jul 10, 2026
First-In-Human [177Lu]Lu-FAPI-XT Therapy Combined With Anti-PD-1 Antibody in a Patient With Metastatic Colon Cancer Who Has Progressed on Multiple Prior Lines of Therapy.

|Jan 07, 2022
Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer.

Miaomiao Gou, Tongtong Qu, Zhikuan Wang

|Jan 25, 2021
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02).

Feng-Hua Wang, Xiao-Li Wei, Jifeng Feng

|Feb 27, 2019
The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer.

Jun Jia, Pengfei Zhang, Miaomiao Gou

Pageof 1

Frequent Collaborators

2 joint publications

Miaomiao Gou

2 joint publications

Yong Zhang

1 joint publications

Xi-Chun Hu

1 joint publications

Lin Shen